These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28315644)

  • 1. Effects of Buprenorphine, Methylnaltrexone, and Their Combination on Gastrointestinal Transit in Healthy New Zealand White Rabbits.
    Martin-Flores M; Singh B; Walsh CA; Brooks EP; Taylor L; Mitchell LM
    J Am Assoc Lab Anim Sci; 2017 Mar; 56(2):155-159. PubMed ID: 28315644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Cisapride, Buprenorphine, and Their Combination on Gastrointestinal Transit in New Zealand White Rabbits.
    Feldman ER; Singh B; Mishkin NG; Lachenauer ER; Martin-Flores M; Daugherity EK
    J Am Assoc Lab Anim Sci; 2021 Mar; 60(2):221-228. PubMed ID: 33632373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral-cecal transit time.
    Yuan CS; Foss JF; Osinski J; Toledano A; Roizen MF; Moss J
    Clin Pharmacol Ther; 1997 Apr; 61(4):467-75. PubMed ID: 9129564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebo-controlled trial.
    Yuan CS; Wei G; Foss JF; O'Connor M; Karrison T; Osinski J
    J Pharmacol Exp Ther; 2002 Jan; 300(1):118-23. PubMed ID: 11752106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intravenous methylnaltrexone on opioid-induced gut motility and transit time changes in subjects receiving chronic methadone therapy: a pilot study.
    Yuan SC; Foss FJ; O'Connor M; Osinski J; Roizen FM; Moss J
    Pain; 1999 Dec; 83(3):631-635. PubMed ID: 10568873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of the opioid antagonist N-methylnaltrexone and evaluation of its effects on gastrointestinal tract function in horses treated or not treated with morphine.
    Boscan P; Van Hoogmoed LM; Pypendop BH; Farver TB; Snyder JR
    Am J Vet Res; 2006 Jun; 67(6):998-1004. PubMed ID: 16740093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial.
    Yuan CS; Foss JF; O'Connor M; Toledano A; Roizen MF; Moss J
    Clin Pharmacol Ther; 1996 Apr; 59(4):469-75. PubMed ID: 8612393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of enteric-coated methylnaltrexone in preventing opioid-induced delay in oral-cecal transit time.
    Yuan CS; Foss JF; O'Connor M; Karrison T; Osinski J; Roizen MF; Moss J
    Clin Pharmacol Ther; 2000 Apr; 67(4):398-404. PubMed ID: 10801249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended-release but not immediate-release and subcutaneous methylnaltrexone antagonizes the loperamide-induced delay of whole-gut transit time in healthy subjects.
    Kolbow J; Modess C; Wegner D; Oswald S; Maritz MA; Rey H; Weitschies W; Siegmund W
    J Clin Pharmacol; 2016 Feb; 56(2):239-45. PubMed ID: 26313157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The selective mu opioid receptor antagonist, alvimopan, improves delayed GI transit of postoperative ileus in rats.
    Fukuda H; Suenaga K; Tsuchida D; Mantyh CR; Pappas TN; Hicks GA; Dehaven-Hudkins DL; Takahashi T
    Brain Res; 2006 Aug; 1102(1):63-70. PubMed ID: 16797494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability, gut effects, and pharmacokinetics of methylnaltrexone following repeated intravenous administration in humans.
    Yuan CS; Doshan H; Charney MR; O'connor M; Karrison T; Maleckar SA; Israel RJ; Moss J
    J Clin Pharmacol; 2005 May; 45(5):538-46. PubMed ID: 15831777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylnaltrexone bromide: new drug for the treatment of opioid-induced bowel dysfunction.
    Baker DE
    Rev Gastroenterol Disord; 2009; 9(3):E84-93. PubMed ID: 19898269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylnaltrexone prevents morphine-induced kaolin intake in the rat.
    Aung HH; Mehendale SR; Xie JT; Moss J; Yuan CS
    Life Sci; 2004 Apr; 74(22):2685-91. PubMed ID: 15043984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of methylnaltrexone alone and in combination with acutely administered codeine on gastrointestinal and colonic transit in health.
    Wong BS; Rao AS; Camilleri M; Manabe N; McKinzie S; Busciglio I; Burton DD; Ryks M; Zinsmeister AR
    Aliment Pharmacol Ther; 2010 Oct; 32(7):884-93. PubMed ID: 20839388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of subcutaneous methylnaltrexone on patient-reported constipation symptoms.
    Iyer SS; Randazzo BP; Tzanis EL; Schulman SL; Zhang H; Wang W; Manley AL
    Value Health; 2011 Jan; 14(1):177-83. PubMed ID: 21211500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of opioid-induced bladder dysfunction by intravenous naloxone and methylnaltrexone.
    Rosow CE; Gomery P; Chen TY; Stefanovich P; Stambler N; Israel R
    Clin Pharmacol Ther; 2007 Jul; 82(1):48-53. PubMed ID: 17392726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical status of methylnaltrexone, a new agent to prevent and manage opioid-induced side effects.
    Yuan CS
    J Support Oncol; 2004; 2(2):111-7; discussion 119-22. PubMed ID: 15328815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylnaltrexone, a novel peripheral opioid receptor antagonist for the treatment of opioid side effects.
    Yuan CS; Israel RJ
    Expert Opin Investig Drugs; 2006 May; 15(5):541-52. PubMed ID: 16634692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylnaltrexone for opioid-induced constipation in pediatric oncology patients.
    Rodrigues A; Wong C; Mattiussi A; Alexander S; Lau E; Dupuis LL
    Pediatr Blood Cancer; 2013 Oct; 60(10):1667-70. PubMed ID: 23766091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of multimodal analgesia with LowDose buprenorphine and meloxicam on fecal glucocorticoid metabolites after surgery in New Zealand white rabbits (Oryctolagus cuniculus).
    Goldschlager GB; Gillespie VL; Palme R; Baxter MG
    J Am Assoc Lab Anim Sci; 2013 Sep; 52(5):571-6. PubMed ID: 24041213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.